Blocking Skp2 protein might inhibit glycolysis and treat breast cancer

[News]

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

More... (http://www.news-medical.net/news/20120528/Blocking-Skp2-protein-might-inhibit-glycolysis-and-treat-breast-cancer.aspx)